Mackenzie Financial
ANAB icon

Mackenzie Financial’s AnaptysBio ANAB Stock Holding History

Mackenzie Financial’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
150,979
+117,259
+348% +$7.11M 0.01% 632
2026
Q1 		$1.87M Buy
33,720
+9,492
+39% +$511K ﹤0.01% 941
2025
Q4 		$1.17M Buy
+24,228
New +$944K ﹤0.01% 1013

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Mackenzie Financial's ANAB Position: Q2 2026 in Review

Mackenzie Financial increased its AnaptysBio (ANAB) stake by 348% in Q2 2026, buying an estimated $7.11M and bringing the position to 150,979 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #632.

Mackenzie Financial first reported a position in ANAB in Q4 2025 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Mackenzie Financial held 150,979 shares of AnaptysBio worth $10.2M as of Q2 2026.
  • Mackenzie Financial bought 117,259 AnaptysBio shares in Q2 2026, an estimated $7.11M.
  • AnaptysBio made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #632 holding.
  • Mackenzie Financial first reported a position in AnaptysBio in Q4 2025 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.